155 related articles for article (PubMed ID: 11798180)
1. Adenovirus-mediated murine interferon-gamma receptor transfer enhances the efficacy of IFN-gamma in vivo.
Nishida Y; Maeda Y; Hara A; Arima T; Kimura E; Yamashita S; Uyama E; Mita S; Uchino M
Biochem Biophys Res Commun; 2002 Jan; 290(3):1042-7. PubMed ID: 11798180
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of tumorigenicity and metastasis of human bladder cancer growing in athymic mice by interferon-beta gene therapy results partially from various antiangiogenic effects including endothelial cell apoptosis.
Izawa JI; Sweeney P; Perrotte P; Kedar D; Dong Z; Slaton JW; Karashima T; Inoue K; Benedict WF; Dinney CP
Clin Cancer Res; 2002 Apr; 8(4):1258-70. PubMed ID: 11948141
[TBL] [Abstract][Full Text] [Related]
3. IFN-gamma regulates murine interferon-inducible T cell alpha chemokine (I-TAC) expression in dendritic cell lines and during experimental autoimmune encephalomyelitis (EAE).
Hamilton NH; Banyer JL; Hapel AJ; Mahalingam S; Ramsay AJ; Ramshaw IA; Thomson SA
Scand J Immunol; 2002 Feb; 55(2):171-7. PubMed ID: 11896933
[TBL] [Abstract][Full Text] [Related]
4. Intratumoral coinjection of two adenoviral vectors expressing functional interleukin-18 and inducible protein-10, respectively, synergizes to facilitate regression of established tumors.
Liu Y; Huang H; Saxena A; Xiang J
Cancer Gene Ther; 2002 Jun; 9(6):533-42. PubMed ID: 12032664
[TBL] [Abstract][Full Text] [Related]
5. Immune gene-viral therapy with triplex efficacy mediated by oncolytic adenovirus carrying an interferon-gamma gene yields efficient antitumor activity in immunodeficient and immunocompetent mice.
Su C; Peng L; Sham J; Wang X; Zhang Q; Chua D; Liu C; Cui Z; Xue H; Wu H; Yang Q; Zhang B; Liu X; Wu M; Qian Q
Mol Ther; 2006 May; 13(5):918-27. PubMed ID: 16497559
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of interferon-gamma by an interferon-gamma receptor immunoadhesin.
Haak-Frendscho M; Marsters SA; Chamow SM; Peers DH; Simpson NJ; Ashkenazi A
Immunology; 1993 Aug; 79(4):594-9. PubMed ID: 8406584
[TBL] [Abstract][Full Text] [Related]
7. IFN-gamma limits macrophage expansion in MRL-Fas(lpr) autoimmune interstitial nephritis: a negative regulatory pathway.
Schwarting A; Moore K; Wada T; Tesch G; Yoon HJ; Kelley VR
J Immunol; 1998 Apr; 160(8):4074-81. PubMed ID: 9558118
[TBL] [Abstract][Full Text] [Related]
8. Intratumoral interferon-alpha gene transfer enhances tumor immunity after allogeneic hematopoietic stem cell transplantation.
Hara H; Kobayashi A; Narumi K; Kondoh A; Yoshida K; Nishimoto T; Ohashi M; Higashihara E; Ohnami S; Yoshida T; Aoki K
Cancer Immunol Immunother; 2009 Jul; 58(7):1007-21. PubMed ID: 18998126
[TBL] [Abstract][Full Text] [Related]
9. Adenovirus-mediated interferon-beta gene transfer inhibits angiogenesis in and progression of orthotopic tumors of human prostate cancer cells in nude mice.
Lee J; Wang A; Hu Q; Lu S; Dong Z
Int J Oncol; 2006 Dec; 29(6):1405-12. PubMed ID: 17088978
[TBL] [Abstract][Full Text] [Related]
10. Postoperative immuno-gene therapy of murine bladder tumor by in vivo administration of retroviruses expressing mouse interferon-gamma.
Shiau AL; Lin CY; Tzai TS; Wu CL
Cancer Gene Ther; 2001 Jan; 8(1):73-81. PubMed ID: 11219496
[TBL] [Abstract][Full Text] [Related]
11. C-terminal deletion mutant p21(WAF1/CIP1) enhances E2F-1-mediated apoptosis in colon adenocarcinoma cells.
Elliott MJ; Stilwell A; Dong YB; Yang HL; Wong SL; Wrightson WR; Martin RC; McMasters KM
Cancer Gene Ther; 2002 May; 9(5):453-63. PubMed ID: 11961668
[TBL] [Abstract][Full Text] [Related]
12. Endogenous interferon gamma protects against cholestatic liver injury in mice.
Sewnath ME; Van Der Poll T; Van Noorden CJ; Ten Kate FJ; Gouma DJ
Hepatology; 2002 Dec; 36(6):1466-77. PubMed ID: 12447873
[TBL] [Abstract][Full Text] [Related]
13. Prevention of autoimmune diabetes by intramuscular gene therapy with a nonviral vector encoding an interferon-gamma receptor/IgG1 fusion protein.
Prud'homme GJ; Chang Y
Gene Ther; 1999 May; 6(5):771-7. PubMed ID: 10505100
[TBL] [Abstract][Full Text] [Related]
14. Targeted in vivo expression of IFN-gamma-inducible protein 10 induces specific antitumor activity.
Yang X; Chu Y; Wang Y; Zhang R; Xiong S
J Leukoc Biol; 2006 Dec; 80(6):1434-44. PubMed ID: 16980511
[TBL] [Abstract][Full Text] [Related]
15. A novel bystander effect involving tumor cell-derived Fas and FasL interactions following Ad.HSV-tk and Ad.mIL-12 gene therapies in experimental prostate cancer.
Hall SJ; Canfield SE; Yan Y; Hassen W; Selleck WA; Chen SH
Gene Ther; 2002 Apr; 9(8):511-7. PubMed ID: 11948376
[TBL] [Abstract][Full Text] [Related]
16. Nitric oxide suppresses human T lymphocyte proliferation through IFN-gamma-dependent and IFN-gamma-independent induction of apoptosis.
Allione A; Bernabei P; Bosticardo M; Ariotti S; Forni G; Novelli F
J Immunol; 1999 Oct; 163(8):4182-91. PubMed ID: 10510354
[TBL] [Abstract][Full Text] [Related]
17. Tumor irradiation followed by intratumoral cytokine gene therapy for murine renal adenocarcinoma.
Hillman GG; Slos P; Wang Y; Wright JL; Layer A; De Meyer M; Yudelev M; Che M; Forman JD
Cancer Gene Ther; 2004 Jan; 11(1):61-72. PubMed ID: 14681727
[TBL] [Abstract][Full Text] [Related]
18. In vitro activation of cancer patient-derived dendritic cells by tumor cells genetically modified to express CD154.
Loskog A; Tötterman TH; Böhle A; Brandau S
Cancer Gene Ther; 2002 Oct; 9(10):846-53. PubMed ID: 12224026
[TBL] [Abstract][Full Text] [Related]
19. Constitutive nuclear factor kappaB activity is required to elicit interferon-gamma-induced expression of chemokine CXC ligand 9 (CXCL9) and CXCL10 in human tumour cell lines.
Hiroi M; Ohmori Y
Biochem J; 2003 Dec; 376(Pt 2):393-402. PubMed ID: 12946268
[TBL] [Abstract][Full Text] [Related]
20. MyD88-mediated stabilization of interferon-gamma-induced cytokine and chemokine mRNA.
Sun D; Ding A
Nat Immunol; 2006 Apr; 7(4):375-81. PubMed ID: 16491077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
